RECRUITING

My Interprofessional Care Team for Adherence and Research Engagement Disparities

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

MI-CARE is an innovative coordinated care team intervention to improve medication adherence and blood pressure derived from research findings that build on existing clinical practice. Designed with an eye toward sustainability, MI-CARE incorporates billable pharmacist and CHW services for patients with low medication adherence and high burdens of chronic illness and preventable consequences. MI-CARE offers interprofessional team care with comprehensive expertise and complementary skill sets that mitigate the silo effect of specialized medicine to deliver primary care to diverse, high-risk populations experiencing disparities in hypertension.

Official Title

Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension

Quick Facts

Study Start:2023-08-30
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05470439

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. age ≥ 18 years;
  2. 2. self-report cultural identity as African-American, or Latino;
  3. 3. speak English, or Spanish;
  4. 4. have medication-treated hypertension;
  5. 5. use ≥5 chronic medications;
  6. 6. have hypertension medication adherence \<85%; and
  7. 7. able to provide informed consent.
  1. 1. if project staff conclude that a candidate participant is unable to comprehend the informed consent process (because he/she offers an inappropriate response to consent questions); or
  2. 2. if the candidate is hostile or unwilling to follow project protocols.

Contacts and Locations

Study Contact

Vrinda Prakash, MPH
CONTACT
413-739-1100
vprakash@caringhealth.org
Susan J Shaw, PhD
CONTACT
413-545-7436
sjshaw@umass.edu

Principal Investigator

Jeannie K Lee, PharmD
PRINCIPAL_INVESTIGATOR
University of Arizona College of Pharmacy

Study Locations (Sites)

Caring Health Center, Inc.
Springfield, Massachusetts, 01103
United States

Collaborators and Investigators

Sponsor: University of Arizona

  • Jeannie K Lee, PharmD, PRINCIPAL_INVESTIGATOR, University of Arizona College of Pharmacy

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-30
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2023-08-30
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • Pharmacist, CHW, Hypertension, Adherence, FQHC

Additional Relevant MeSH Terms

  • Medication Adherence
  • Hypertension